Երկիր: Միացյալ Թագավորություն
Լեզու: անգլերեն
Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)
L-Tyrosine; L-Tryptophan; L-Phenylalanine; L-Serine; L-Proline; Glycine; L-Alanine; L-Valine; L-Isoleucine; L-Leucine; L-Lysine monohydrochloride; Calcium chloride dihydrate; Magnesium chloride hexahydrate; Sodium lactate; Sodium chloride; L-Histidine; L-Threonine; L-Arginine; L-Methionine
Baxter Healthcare Ltd
n/a
L-Tyrosine; L-Tryptophan; L-Phenylalanine; L-Serine; L-Proline; Glycine; L-Alanine; L-Valine; L-Isoleucine; L-Leucine; L-Lysine monohydrochloride; Calcium chloride dihydrate; Magnesium chloride hexahydrate; Sodium lactate; Sodium chloride; L-Histidine; L-Threonine; L-Arginine; L-Methionine
300mg/1litre ; 270mg/1litre ; 570mg/1litre ; 510mg/1litre ; 595mg/1litre ; 510mg/1litre ; 951mg/1litre ; 1.393gram/1litre ; 850mg/1litre ; 1.02gram/1litre ; 955mg/1litre ; 184mg/1litre ; 51mg/1litre ; 4.48gram/1litre ; 5.38gram/1litre ; 714mg/1litre ; 646mg/1litre ; 1.071gram/1litre ; 850mg/1litre
Solution for peritoneal dialysis
Intraperitoneal
No Controlled Drug Status
Never Valid To Prescribe As A VMP
BNF: ; GTIN: 5413760441917
OBJECT 1 NUTRINEAL PD4 WITH 1.1% AMINO ACIDS. Summary of Product Characteristics Updated 06-Dec-2017 | Baxter Healthcare Ltd 1. Name of the medicinal product Nutrineal PD4 with 1.1% amino acids. 2. Qualitative and quantitative composition L-Tyrosine 300 mg/l L-Tryptophan 270 mg/l L-Phenylalanine 570 mg/l L-Threonine 646 mg/l L-Serine 510 mg/l L-Proline 595 mg/l Glycine 510 mg/l L-Alanine 951 mg/l L-Valine 1393 mg/l L-Methionine 850 mg/l L-Isoleucine 850 mg/l L-Leucine 1020 mg/l L-Lysine hydrochloride 955 mg/l L-Histidine 714 mg/l L-Arginine 1071 mg/l Calcium chloride dihydrate 184 mg/l Magnesium chloride hexahydrate 51 mg/l Sodium S-Lactate 4480 mg/l Sodium Chloride 5380 mg/l For the full list of excipients, see section 6.1. 3. Pharmaceutical form Peritoneal dialysis solution contained in bags. 4. Clinical particulars 4.1 Therapeutic indications Nutrineal is recommended as a non-glucose based peritoneal dialysis solution as part of a peritoneal dialysis regimen for the treatment of chronic renal failure patients. In particular, it is recommended for the malnourished peritoneal dialysis patients. 4.2 Posology and method of administration ADMINISTRATION Nutrineal is intended for intraperitoneal administration only. Not for intravenous administration. Peritoneal dialysis solutions may be warmed in the overpouch to 37°C to enhance patient comfort. However, only dry heat (for example, heating pad, warming plate) should be used. Solutions should not be heated in water due to an increased risk of contamination. Solutions should not be heated in a microwave oven due to the potential for damage to the solutions container and patient injury or discomfort. Aseptic technique should be employed throughout the peritoneal dialysis procedure. Do not administer if the solution is discoloured, cloudy, contains particulate matter or shows evidence of leakage, or if seals are not intact. The drained fluid should be inspected for the presence of fibrin or cloudiness, which may indicate the presence of peritonitis. For single use onl Կարդացեք ամբողջական փաստաթուղթը